Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Shares Issued (2024 - 2025)

Rxo (RXO) has disclosed Shares Issued for 2 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued rose 103.33% year-over-year to $1.0 million, compared with a TTM value of $1.1 billion through Dec 2025, changed N/A, and an annual FY2024 reading of $1.1 billion, changed N/A over the prior year.
  • Shares Issued was $1.0 million for Q3 2025 at Rxo, down from $1.2 billion in the prior quarter.
  • Across five years, Shares Issued topped out at $1.2 billion in Q4 2024 and bottomed at -$30.0 million in Q3 2024.